Your browser doesn't support javascript.
loading
MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma.
Miranda-Gonçalves, Vera; Gonçalves, Céline S; Granja, Sara; Vieira de Castro, Joana; Reis, Rui M; Costa, Bruno M; Baltazar, Fátima.
Affiliation
  • Miranda-Gonçalves V; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
  • Gonçalves CS; ICVS/3Bs-PT Government Associate Laboratory, 4805-017 Guimarães, Portugal.
  • Granja S; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
  • Vieira de Castro J; ICVS/3Bs-PT Government Associate Laboratory, 4805-017 Guimarães, Portugal.
  • Reis RM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
  • Costa BM; ICVS/3Bs-PT Government Associate Laboratory, 4805-017 Guimarães, Portugal.
  • Baltazar F; Research Centre in Health and Environment (CISA), School of Health (ESS), Polytechnic Institute of Porto (P.PORTO), 4200-072 Porto, Portugal.
Cancers (Basel) ; 13(14)2021 Jul 11.
Article in En | MEDLINE | ID: mdl-34298681
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Country of publication: